GlobeStar Therapeutics Co. (OTCMKTS:GSTC) Short Interest Update

GlobeStar Therapeutics Co. (OTCMKTS:GSTC) was the target of a significant increase in short interest in October. As of October 31st, there was short interest totalling 336,400 shares, an increase of 146.1% from the October 15th total of 136,700 shares. Based on an average daily volume of 14,596,100 shares, the short-interest ratio is presently 0.0 days.

GlobeStar Therapeutics Price Performance

OTCMKTS GSTC opened at $0.00 on Friday. GlobeStar Therapeutics has a 52 week low of $0.00 and a 52 week high of $0.00.

About GlobeStar Therapeutics

GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. It offers Amethyst, a compound intended to treat neurodegeneration. The company was formerly known as AngioSoma, Inc and changed its name to GlobeStar Therapeutics Corporation in July 2021.